193 related articles for article (PubMed ID: 36566591)
1. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.
Zwezerijnen-Jiwa FH; Sivov H; Paizs P; Zafeiropoulou K; Kinross J
Neoplasia; 2023 Feb; 36():100868. PubMed ID: 36566591
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
[TBL] [Abstract][Full Text] [Related]
3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
4. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
5. Microbial markers in colorectal cancer detection and/or prognosis.
Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
[TBL] [Abstract][Full Text] [Related]
6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
7. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
8. Significance of the gut microbiome in multistep colorectal carcinogenesis.
Mizutani S; Yamada T; Yachida S
Cancer Sci; 2020 Mar; 111(3):766-773. PubMed ID: 31910311
[TBL] [Abstract][Full Text] [Related]
9. A multiple-dimension model for microbiota of patients with colorectal cancer from normal participants and other intestinal disorders.
Shen J; Jin G; Zhang Z; Zhang J; Sun Y; Xie X; Ma T; Zhu Y; Du Y; Niu Y; Shi X
Appl Microbiol Biotechnol; 2022 Mar; 106(5-6):2161-2173. PubMed ID: 35218389
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome: New biomarkers in early screening of colorectal cancer.
Zhou P; Yang D; Sun D; Zhou Y
J Clin Lab Anal; 2022 May; 36(5):e24359. PubMed ID: 35312122
[TBL] [Abstract][Full Text] [Related]
11. Faecal microbial biomarkers in early diagnosis of colorectal cancer.
Olovo CV; Huang X; Zheng X; Xu M
J Cell Mol Med; 2021 Dec; 25(23):10783-10797. PubMed ID: 34750964
[TBL] [Abstract][Full Text] [Related]
12. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
13. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
Liu Y; Lau HC; Cheng WY; Yu J
Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
[TBL] [Abstract][Full Text] [Related]
14. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.
Zhang S; Kong C; Yang Y; Cai S; Li X; Cai G; Ma Y
Theranostics; 2020; 10(25):11595-11606. PubMed ID: 33052235
[No Abstract] [Full Text] [Related]
15. Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.
van Liere ELSA; de Boer NKH; Dekker E; van Leerdam ME; de Meij TGJ; Ramsoekh D
Aliment Pharmacol Ther; 2022 Apr; 55(7):778-788. PubMed ID: 35181895
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Potential of Oral Microbiome Biomarkers for Colorectal Cancer Diagnosis and Prognosis: A Systematic Review.
Negrut RL; Cote A; Maghiar AM
Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375087
[TBL] [Abstract][Full Text] [Related]
18. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
[TBL] [Abstract][Full Text] [Related]
19. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
20. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
